Cargando…
New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
Despite advances in pharmacotherapy, diabetic kidney disease (DKD) remains associated with a high burden of micro‐ and macrovascular complications often leading to premature mortality. New therapies are highly desirable to mitigate the burden of this disease. However, there are a number of barriers...
Autores principales: | Heerspink, Hiddo J. L., List, James, Perkovic, Vlado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220936/ https://www.ncbi.nlm.nih.gov/pubmed/30294954 http://dx.doi.org/10.1111/dom.13417 |
Ejemplares similares
-
Treating diabetic complications; from large randomized clinical trials to precision medicine
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018) -
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
por: Mol, Peter G. M., et al.
Publicado: (2018) -
Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives
por: de Vries, Jeroen K., et al.
Publicado: (2018) -
4429 Powering precision medicine research with the efficient construction of large diverse cohorts
por: Petukhova, Lynn, et al.
Publicado: (2020) -
Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center
por: Yuan, Christina M., et al.
Publicado: (2017)